炎症营养相关指标与肝癌预后相关性研究进展
Progress in the Study of the Correlation between Inflammation-Nutrition-Related Indexes and Prognosis of Hepatocellular Carcinoma
摘要: 肝细胞癌(HCC)，是肝脏上皮恶性肿瘤中最常见的病理类型，在全球发病率和死亡率很高。近年来，营养不良问题长期被临床医师忽视，严重影响肝癌患者的预后及转归。炎症和营养相关指标检测计算简单快捷，与多种癌症的预后相关。不同患者个体间营养状况、全身炎症免疫反应的差异，致使其预后结局不尽相同。本文综述了炎症和营养相关指标对肝癌肝切除术后患者预后的预测价值等相关方面的研究现状与进展。
Abstract: Hepatocellular carcinoma (HCC), the most common pathological type of epithelial malignancy of the liver, has a high global morbidity and mortality rate. In recent years, malnutrition has long been neglected by clinicians, which seriously affects the prognosis and regression of hepatocellular car-cinoma patients. Inflammation- and nutrition-related indexes, as an easy-to-detect indicator, have been shown to affect the prognosis of many cancers. Differences in nutritional status and systemic inflammatory immune response among different patients lead to different prognostic outcomes. This article reviews the current status and progress of research on the predictive value of inflam-mation- and nutrition-related indicators on the prognosis of patients after hepatectomy for hepato-cellular carcinoma.
文章引用：解安达, 戴勇. 炎症营养相关指标与肝癌预后相关性研究进展[J]. 临床医学进展, 2024, 14(3): 79-84. https://doi.org/10.12677/ACM.2024.143668

参考文献

[1] Sung, H., Ferlay, J., Siegel, R.L., et al. (2021) Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, 71, 209-249. [Google Scholar] [CrossRef] [PubMed]
[2] Zheng, R., Qu, C., Zhang, S., et al. (2018) Liver Cancer Incidence and Mortality in China: Temporal Trends and Projections to 2030. Chinese Journal of Cancer Research, 30, 571-579. [Google Scholar] [CrossRef] [PubMed]
[3] Llovet, J.M., Kelley, R.K., Villanueva, A., et al. (2021) Hepatocellular Carcinoma. Nature Reviews Disease Primers, 7, Article No. 6. [Google Scholar] [CrossRef] [PubMed]
[4] Tanizaki, J., Haratani, K., Hayashi, H., et al. (2018) Peripheral Blood Biomarkers Associated with Clinical Outcome in Non-Small Cell Lung Cancer Patients Treated with Nivolumab. Journal of Thoracic Oncology, 13, 97-105. [Google Scholar] [CrossRef] [PubMed]
[5] Marquardt, J.U. and Thorgeirsson, S.S. (2014) SnapShot: Hepato-cellular Carcinoma. Cancer Cell, 25, 550-550.e1. [Google Scholar] [CrossRef] [PubMed]
[6] Hanahan, D. and Weinberg, R.A. (2011) Hallmarks of Cancer: The Next Generation. Cell, 144, 646-674. [Google Scholar] [CrossRef] [PubMed]
[7] Hendry, S., Salgado, R., Gevaert, T., et al. (2017) Assessing Tumor Infiltrating Lymphocytes in Solid Tumors: A Practical Review for Pathologists and Proposal for A Standardized Method from the International Immuno-Oncology Biomarkers Working Group: Part 1: Assessing the Host Immune Response, TILs in Invasive Breast Carcinoma and Ductal Carcinoma in Situ, Metastatic Tumor Deposits and Areas for Further Re-search. Advances in Anatomic Pathology, 24, 235-251. [Google Scholar] [CrossRef] 
[8] Huang, H., Zhang, L., Chen, D., et al. (2019) Validation of Prognosis Value of Cumulative Prognostic Scores Based on Serum High-Density Lipoprotein Cholesterol and Albumin Levels in Patients with Colorectal Cancer. Journal of Cancer, 10, 35-42. [Google Scholar] [CrossRef] [PubMed]
[9] Onate-Ocana, L.F., Aiello-Crocifoglio, V., Gallardo-Rincon, D., et al. (2007) Serum Albumin as a Significant Prognostic Factor for Patients with Gastric Carcinoma. Annals of Surgical Oncology, 14, 381-389. [Google Scholar] [CrossRef] [PubMed]
[10] McMillan, D.C. (2009) Systemic Inflammation, Nutritional Status and Survival in Patients with Cancer. Current Opinion in Clinical Nutrition and Metabolic Care, 12, 223-226. [Google Scholar] [CrossRef] 
[11] Lien, Y.C., Hsieh, C.C., Wu, Y.C., et al. (2004) Preopera-tive Serum Albumin Level Is a Prognostic Indicator for Adenocarcinoma of the Gastric Cardia. Journal of Gastrointesti-nal Surgery, 8, 1041-1048. [Google Scholar] [CrossRef] [PubMed]
[12] Zhang, G., Zhang, D., Wu, J., et al. (2018) Low Serum Levels of Pre-Surgical Total Cholesterol Are Associated with Unfavorable Overall Survival in Patients with Operable Non-Small Cell Lung Cancer. Clinical Laboratory, 64. [Google Scholar] [CrossRef] 
[13] 万妍, 刘芳, 郭闪, 等. 非肝硬化乙型肝炎病毒相关肝细胞癌的转录组测序及其对患者生存的影响[J]. 首都医科大学学报, 2023, 44(5): 811-820.
[14] Qi, Q., Zhuang, L., Shen, Y., et al. (2016) A Novel Systemic Inflammation Response Index (SIRI) for Predicting the Survival of Patients with Pancreatic Cancer after Chemotherapy. Cancer, 122, 2158-2167. [Google Scholar] [CrossRef] [PubMed]
[15] Cao, Y., Zheng, X., Hu, Y., et al. (2023) Levels of Systemic Inflammation Response Index Are Correlated with Tumor-Associated Bacteria in Colorectal Cancer. Cell Death & Disease, 14, Article No. 69. [Google Scholar] [CrossRef] [PubMed]
[16] 朱梦柳, 陈力, 孔祥溢, 等. 全身炎症反应指数(SIRI)在乳腺癌患者中的临床意义和预后价值[J]. 现代肿瘤医学, 2022, 30(3): 442-450.
[17] Zhao, M., Duan, X., Mi, L., et al. (2022) Prognosis of Hepatocellular Carcinoma and Its Association with Immune Cells Using Systemic Inflammatory Response Index. Future Oncology, 18, 2269-2288. [Google Scholar] [CrossRef] [PubMed]
[18] 张劲夫, 范正军, 梁润威, 等. 术前SIRI和PLR对肝癌切除术后病人生存预测价值分析[J]. 中国实用外科杂志, 2018, 38(2): 210-218. [Google Scholar] [CrossRef] 
[19] 李婵, 吴远鹏, 吴吉进, 等. SII预测恶性实体肿瘤预后的研究进展[J]. 实用医院临床杂志, 2018, 15(3): 252-254.
[20] Hu, B., Yang, X.R., Xu, Y., et al. (2014) Systemic Immune-Inflammation Index Predicts Prognosis of Patients after Curative Resection for Hepatocellular Carci-noma. Clinical Cancer Research, 20, 6212-6222. [Google Scholar] [CrossRef] 
[21] Xu, J., Hu, S., Li, S., et al. (2021) Systemic Im-mune-Inflammation Indexpredicts Postoperative Acute Kidney Injury in Hepatocellular Carcinoma Patients After Hepa-tectomy. Medicine, 100, e25335. [Google Scholar] [CrossRef] 
[22] Galizia, G., Lieto, E., Auricchio, A., et al. (2017) Naples Prognostic Score, Based on Nutritional and Inflammatory Status, Is an Independent Predictor of Long-Term Outcome in Patients Undergoing Surgery for Colorectal Cancer. Diseases of the Colon & Rectum, 60, 1273-1284. [Google Scholar] [CrossRef] 
[23] 闫可, 魏菀怡, 沈文斌, 等. 那不勒斯预后评分对临床III期食管癌患者预后的预测价值[J]. 天津医药, 2022, 50(4): 408-413.
[24] Nakagawa, N., Yamada, S., Sonohara, F., et al. (2020) Clinical Implications of Naples Prognostic Score in Patients with Resected Pancreatic Cancer. Annals of Surgical Oncology, 27, 887-895. [Google Scholar] [CrossRef] [PubMed]
[25] Wang, D., Hu, X., Xiao, L., et al. (2021) Prognostic Nutritional Index and Systemic Immune-Inflammation Index Predict the Prognosis of Patients with HCC. Journal of Gastrointesti-nal Surgery, 25, 421-427. [Google Scholar] [CrossRef] [PubMed]
[26] Buzby, G.P., Mullen, J.L., Matthews, D.C., et al. (1980) Prog-nostic Nutritional Index in Gastrointestinal Surgery. The American Journal of Surgery, 139, 160-167. [Google Scholar] [CrossRef] [PubMed]
[27] Liu, J., Dai, Y., Zhou, F., et al. (2016) The Prognostic Role of Preoperative Serum Albumin/Globulin Ratio in Patients with Bladder Urothelial Carcinoma Undergoing Radical Cystec-tomy. Urologic Oncology: Seminars and Original Investigations, 34, 484.e1-484.e8. [Google Scholar] [CrossRef] [PubMed]
[28] Carr, B.I. and Guerra, V. (2017) Serum Albumin Levels in Re-lation to Tumor Parameters in Hepatocellular Carcinoma Patients. The International Journal of Biological Markers, 32, 391-396. [Google Scholar] [CrossRef] [PubMed]
[29] 吴光柳, 周小英, 杨雪梅, 等. 预后营养指数评估原发性肝癌肝切除病人预后的Meta分析[J]. 循证护理, 2024, 10(3): 392-395.

为你推荐